PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00544219
Recruitment Status : Completed
First Posted : October 16, 2007
Last Update Posted : June 15, 2016
Information provided by (Responsible Party):
Swiss Group for Clinical Cancer Research